|
Originally published In Press as doi:10.1074/jbc.M106288200 on August 3, 2001
J. Biol. Chem., Vol. 276, Issue 42, 38988-38994, October 19, 2001
Antiviral Activity and Structural Characteristics of the
Nonglycosylated Central Subdomain of Human Respiratory Syncytial Virus
Attachment (G) Glycoprotein*
Jeffrey J.
Gorman ,
Jennifer L.
McKimm-Breschkin§,
Raymond S.
Norton¶, and
Kevin J.
Barnham
From the Biomolecular Research Institute, 343 Royal Parade,
Parkville, Victoria 3052, Australia
Segments of the cystine noose-containing
nonglycosylated central subdomain, residues 149-197, of the attachment
(G) glycoprotein of human respiratory syncytial virus (HRSV) have been
assessed for impact on the cytopathic effect (CPE) of respiratory
syncytial virus (RSV). N -acetyl residues 149-197-amide (G149-197),
G149-189, and G149-177 of the A2 strain of HRSV protected 50% of
human epithelial HEp-2 cells from the CPE of the A2 strain at
concentrations (IC50) between 5 and 80 µM. Cystine noose-containing peptides G171-197 and
G173-197 did not inhibit the CPE even at concentrations above 150 µM. Systematic C- and N-terminal truncations from
G149-189 and G149-177 and alanine substitutions within G154-177
demonstrated that residues 166-170 (EVFNF), within a sequence that is
conserved in HRSV strains, were critical for inhibition. Concordantly,
G154-177 of bovine RSV and of an antibody escape mutant of HRSV with
residues 166-170 of QTLPY and EVSNP, respectively, were not
inhibitory. Surprisingly, a variant of G154-177 with an E166A
substitution had an IC50 of 750 nM. NMR
analysis demonstrated that G149-177 adopted a well-defined
conformation in solution, clustered around F168 and F170. G154-170,
particularly EVFNF, may be important in binding of RSV to host cells.
These findings constitute a promising platform for the
development of antiviral agents for RSV.
*
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: CSIRO Health
Sciences and Nutrition, 343 Royal Parade, Parkville, Victoria
3052, Australia. Tel.: 61-3-9662-7309; Fax: 61-3-9662-7101;
E-mail: jeff.gorman@hsn.csiro.au.
§
Present address: CSIRO Health Sciences and Nutrition, 343 Royal
Parade, Parkville, Victoria 3052, Australia.
¶
Present address: The Walter and Eliza Hall Institute of
Medical Research, PO Royal Melbourne Hospital, Victoria 3050, Australia.
Present address: Department of Pathology, University of
Melbourne, Parkville, Victoria 3010, Australia.
Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
E. Escribano-Romero, J. Rawling, B. Garcia-Barreno, and J. A. Melero
The Soluble Form of Human Respiratory Syncytial Virus Attachment Protein Differs from the Membrane-Bound Form in Its Oligomeric State but Is Still Capable of Binding to Cell Surface Proteoglycans
J. Virol.,
April 1, 2004;
78(7):
3524 - 3532.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. J. Budge, J. Lebowitz, and B. S. Graham
Antiviral Activity of RhoA-Derived Peptides against Respiratory Syncytial Virus Is Dependent on Formation of Peptide Dimers
Antimicrob. Agents Chemother.,
November 1, 2003;
47(11):
3470 - 3477.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. N. Teng and P. L. Collins
The Central Conserved Cystine Noose of the Attachment G Protein of Human Respiratory Syncytial Virus Is Not Required for Efficient Viral Infection In Vitro or In Vivo
J. Virol.,
May 13, 2002;
76(12):
6164 - 6171.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|